HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,758 | -82.3% | 25,267 | -81.6% | 0.01% | -84.7% |
| Q4 2022 | $15,610 | -99.8% | 137,167 | -14.4% | 0.06% | +40.5% |
| Q3 2022 | $9,922,000 | -45.1% | 160,315 | -29.3% | 0.04% | -47.5% |
| Q2 2022 | $18,086,000 | -24.9% | 226,760 | -1.0% | 0.08% | -13.0% |
| Q1 2022 | $24,096,000 | +26.8% | 229,028 | +29.9% | 0.09% | +26.0% |
| Q4 2021 | $19,004,000 | +2.3% | 176,353 | +4.0% | 0.07% | -3.9% |
| Q3 2021 | $18,574,000 | +45.3% | 169,565 | +24.2% | 0.08% | +26.7% |
| Q2 2021 | $12,782,000 | +78.2% | 136,502 | +75.2% | 0.06% | +62.2% |
| Q1 2021 | $7,172,000 | +47.1% | 77,925 | +17.0% | 0.04% | +32.1% |
| Q4 2020 | $4,874,000 | -3.1% | 66,626 | +2.9% | 0.03% | -12.5% |
| Q3 2020 | $5,032,000 | +38.7% | 64,773 | -0.7% | 0.03% | +33.3% |
| Q2 2020 | $3,627,000 | – | 65,261 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |